At Eclipse BioInnovations (Eclipse Bio), we create tools that simplify, accelerate and advance RNA research. End-Seq technology is a recent development at Eclipse Bio, which we are excited to officially launch this month. Eclipse’s End-Seq products enable researchers to map both 5’ and 3’ transcript ends genome-wide at single nucleotide resolution in just 3 short days, and overcome several drawbacks associated with previous methods used to map transcript ends like long protocols and low-resolution data.
Related Posts
At Eclipse BioInnovations (Eclipse Bio), we create tools that simplify, accelerate and advance RNA research. End-Seq technology is a recent development at Eclipse Bio, which we are excited to officially launch this month. Eclipse’s End-Seq products enable researchers to map both 5’ and 3’ transcript ends genome-wide at single nucleotide resolution in just 3 short days, and overcome several drawbacks associated with previous methods used to map transcript ends like long protocols and low-resolution data.
Related Posts
Recent Posts
New method allows scientists to follow gene activity over time in the same cells
Single-cell and single-embryo RNA sequencing
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Deep learning improves microRNA target prediction from sequence
New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It
Atlas of the brain’s striatum could guide researchers to new drug treatments
RNA-Seq Products & Services
Stay Connected